Hossam Zaki to Asharq Al-Awsat: The Plan to Displace Palestinians will not be Successful

Ambassador Hossam Zaki, Assistant Secretary-General of the Arab League (Asharq Al-Awsat)
Ambassador Hossam Zaki, Assistant Secretary-General of the Arab League (Asharq Al-Awsat)
TT

Hossam Zaki to Asharq Al-Awsat: The Plan to Displace Palestinians will not be Successful

Ambassador Hossam Zaki, Assistant Secretary-General of the Arab League (Asharq Al-Awsat)
Ambassador Hossam Zaki, Assistant Secretary-General of the Arab League (Asharq Al-Awsat)

The Arab League confirmed that an emergency summit, which will be held on Saturday in Saudi Arabia, will express a solid Arab position in support of Palestinian rights, and convey an Arab-Palestinian message to the world about the centrality of the political solution to the Palestinian cause.

In an interview with Asharq Al-Awsat, the assistant secretary general of the Arab League, Ambassador Hossam Zaki, said that Arab foreign ministers will discuss on Thursday the draft resolution submitted by Palestine, and come up with a common stance.

The Arab diplomat stressed that western countries have “fallen morally in the current Gaza crisis,” adding that all talk of human rights and respect for them “has vanished when speaking about the Palestinian human being.”

Zaki considered that the positions of Moscow and Beijing were more rational than that of the West.

“Russia and China are friendly countries and have a much greater understanding of what is happening... This situation enables them to adopt better, more balanced and rational positions than the West. We do not say that they are with us one hundred percent, but they stand in much better positions,” he said.

Asked about his assessment of the US position on the Gaza crisis, the official said it is “a stance that is not positive, to say the least, and is very unfair towards the Palestinian situation and Palestinian rights.”

The official expressed an Arab determination to thwart any Israeli plans to forcibly displace Palestinians from their lands, noting that the Arab League will establish a mechanism to monitor Israeli genocide crimes and follow them up legally.

Regarding Arab perceptions of the future of the Gaza Strip, he said: “The Arabs refuse to talk about this matter before the ceasefire.”

Although “the Arab League is not a party to the ongoing ceasefire efforts,” according to Zaki, it “is actively following these endeavors...”

“The Israeli side is still rejecting the ceasefire, and is trying to barter the truce for the release of the hostages... There are Arab and other parties assuming roles in this effort.”

He also confirmed the presence of an Israeli plan to displace the Palestinians, saying: “Yes, we are convinced that Israel has this project, ambitions, and these ideas, but, God willing, we will thwart it completely.”

Zaki went on to say: “The Palestinian issue is not a security file, or a ‘war on terrorism’ issue... This is a complex issue with backgrounds and a history known to everyone, and the world must continue to view it as a political problem and deal with it on this basis.”

A few days before the emergency Arab summit hosted by Riyadh, the Arab League assistant secretary-general said that preparations were proceeding at an excellent pace.

He added that the Arab ministerial meeting will “discuss the draft resolution proposed by Palestine, which will include a set of elements that address the political situation.”



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.